Patient Dies During Pfizer Hemophilia Drug Trial
-
LN24 / 6 days
- 0
- 2 min read
A participant in Pfizer’s long-term clinical study of its hemophilia treatment Hympavzi has died after suffering serious complications, raising concerns about the safety oversight and design of the trials. The patient passed away on December 14 following a stroke and subsequent brain hemorrhage, according to the European Haemophilia Consortium. The individual was enrolled in a […]